User:Asema24

Asema Maratova 2024 Geromics Course

Asema Maratova

Contact: asema24@unist.ac.kr

Department: Biological Science 

Interest:  DNA damage and repair, cancer 

Asema Maratova 
20225573
 

<v:shape id="Straight_x0020_Arrow_x0020_Connector_x0020_4" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI +gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5 8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEAYDIt198BAACqBAAA HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWysVNtunDAQfa/Uf7D83gC7NMmisFG1 TfNStVG2/YCRMWDVjJHtEvbvO+a2q1WUqklfwGbOOXNmxubmtm8066R1ymDOk4uYM4nCFAqrnP/8 8eXDNWfOAxagDcqcH6Tjt9v3724gqyy0tRKMFNBlkPPa+zaLIidq2YC7MK1EipXGNuBpa6uosPBE yo2OVnF8GTWgkG+PUp/BA/tt1SuktBG/ZLED7MCRpBbZ6ZfJoxZvV4YMu3vb7tsHG5yLb92DZarI OXUOoaEW8WgKTDDaRmes6ijQl7YJeFOWrM/5mhqTxqR1oGls4quPaTzqyd4zQYD0enUZ4oIAV6v1 htZjvvr7XxREffeiBpkczdDixKDocd8Gh9jtwvK87mSVrpNks0mSuQF7b0FVtWefrDVPbGcQpfDG snRpzaQ0t+ZE2E0J/k9flpoga63z99I0LCxy7iaTi7tkOInQfXV+tDUTQu0aw7OWUNxhwfyhpTl7 qwArLceiPCj9fIw8BDq95tqcP2g5yj7Kkk4PzXVMP9wdudOWdaBzDkJI9EnIMKgQOtBKpfVCjAff LxInfKDKsqRZ/At5YQyZDR7JjUJjn8vu+9lyOeLH6seqqZDpSEVnt3RATX+V8Cs43W//AAAA//8D AFBLAwQUAAYACAAAACEAUD+iyxoHAABNIAAAGgAAAGNsaXBib2FyZC90aGVtZS90aGVtZTEueG1s 7FpLbxs3EL4X6H8g9t5YkiXZMiIHli3HTfxCpKTIkZKoXcbc5YKk7OhWJKdeChRIi14K9NZDUTRA AzTopT/GQII2/REdch8iJSp+IECDwjZg7M5+MxzOzM7MDn37ztOYoVMiJOVJO6jeqgSIJEM+oknY Dh72dz9bD5BUOBlhxhPSDqZEBnc2P/3kNt4YMpoOOBajfkRigkBQIjdwO4iUSjdWVuQQyFje4ilJ 4NmYixgruBXhykjgM1ggZiu1SqW5EmOaBJsgUWlBXQZ/EiU1YchET4shKMExrH40HtMhMdjRSVUj 5FRuM4FOMWsHIHPEz/rkqQoQw1LBg3ZQMT/ByubtFbyRMzG1hNfi2zU/OV/OMDqpmTVFOCgXrXRr 6/VqKd8AmFrEddf1bynPAPBwCDvNdLFlVhvNynotx1qg7NIju7VWXXXxlvzVBZ2rrWanVnfkG1Am v76Ar+y2ujsNB29AGb6xgN+q1DqtVQdvQBm+uYCvd7fWal0Hb0ARo8nJIrq5tr7ezNElZMzZnhfe ajYrazs5fIaCaCijSy8x5olaFmsxfsLFLgA0kGFFE6SmKRnjIcTkVqq4RDtUpgxPA5TihEsgV2rV KoRevVIrf43F8QbBFrfWCzSRCyStD5JDQVPVDu6B1MCCvHn9+vzZq/Nnv58/f37+7Fe0T8NIZaIc vj2chDbfu5+++eeHL9Hfv/347sW3fry08W9/+ertH3++Tzy8ajNTvPnu5dtXL998//VfP7/wSN8S eGDD+zQmEh2SM/SAx7BBYwpXfzIQV+PoR5jaHFtJKHGC9Soe+V0VOejDKWbYg+sQ146PBKQaH/Du 5ImjcC8SE0U9Eu9HsQM84Jx1uPBa4b5eyzJzf5KE/sXFxMY9wPjUt/Y2Thwvdycp5FjqE7kdEUfN Y4YThUOSEIX0M35CiGd3jyl17HpAh4JLPlboMUUdTL0m6dOBE00zpj0ag1+mPgXB345tDh6hDme+ Xe+QUxcJ7wZmHuX7hDlmvIsnCsc+kX0cM9vg+1hFPiV7UzG0cV2pwNMhYRx1R0RKH8+RgP1aTr+P Ibt53X7AprGLFIqe+GTuY85t5A4/2Y5wnPqwPZpENvZzeQIhitExVz74AXffEH0PfsDJUnc/osRx 98XZ4CFkOVulWYDoJxPh8eVdwp347U3ZGBNfqtkSsZNitwT1RkdnEjqhvU8Iw2d4RAh6+LlHgw5P HZvPlL4XQVbZI77AuofdWNX3CZEEmeZmMU/uU+mEbI+EfIk+B9O5xDPFSYzFMsmH4HXb5t2BgJfR s88jNjyxgYcU+j2IF69RjiTIsIJ7qdTjCDsFTN9Lf7xOheO/y7xj8F4+cdS4xHsJPOTKPJDYbZ73 2qaPmbPALGD6mKJ9X7oFFsf9MxZdXA3bxMs3dl/amRugO3KanpgmF3RA/03n4wnED9Pz+AU7CeuK 3c6yhLI31+Msw813NttcjOjH39js4ElyTKCWLGatm77mpq8J/vd9zbL3+aabWdZz3HQzAXQZN91M PmD5MN3MrIGB3kYPGbJhjxn9xEsnP2PKWE9NGdmXZvgj4ZtmtAtEzWcmnKScBKYRXOoyBws4uFBg w4MEV19QFfUinMKEqBpoIaHMRYcSpVzC4MiQvbI1nk3iAz7KBp5mwlTJKqvEakavNGD0lNFhWKUy dHMtJ2r9zFQV9DXahmbYWiigea+ihLWYq8SqR4m1gniBEnp29mG0aHm0WNfiC1ctmAJUK70CH90I PtXbQaOuFYLxuBxCgz7SfspcXXjXOPNDenqZMZ0IgOFithOYnpeebmldl25P7y4LtUt42lHCOCUL K1cJYxnT4MkIPoXz6NTUy6hxVV+3Zi511NOmMOtBfM/UWFt/nxbX9TXwzecGltiZgiXorB00VxsQ MkOctoMxDI7hMk4hdqT+7sIshCOXoRLZC3+dzJIKqXawjDKDm6STuSemigjEaNwO9PZLN7DE5BCj W7UGCeGjVa4FaeVjUw6c7jqZjMdkqGy3WxRt6ewWMnyWK7xPDfv1wZqTT8DdvWh0hgZsIh5gCLHG WlUbcEQlnB9UM2uOKByIlYlsFn9zhSlP/vaJlImhjI5ZGuG8otjJPIObelKqY+5KG1h3+Z7BoJZJ 8kI4CHWBtY3qVNOydGU6LK26FzNpy1lJc1Yznayiq6Y/izkrFGVgzpbXK/KWVoWJIafZFT5L3fMp t1Xkurk+oawSYPDSftcr/ZZqs8Uc1bTGi2lY5+yc6taOYoMXqHaZImFl/WYhds5uZY3wLgfEa1V+ 4JuPWiCNi77SWNp3uH2AUzQIq+0ADphhQPgUruCIOgBaTdNqmgZXcO4M5SI7LG4H+UVBgecZpcSs FpTVAlMvKPWC0igojYLSLCjNAJlTVTjJ1weqASoOTaGG5YeseW/h/gfA5r8AAAD//wMAUEsDBBQA BgAIAAAAIQCcZkZBuwAAACQBAAAqAAAAY2xpcGJvYXJkL2RyYXdpbmdzL19yZWxzL2RyYXdpbmcx LnhtbC5yZWxzhI/NCsIwEITvgu8Q9m7SehCRJr2I0KvUBwjJNi02PyRR7Nsb6EVB8LIws+w3s037 sjN5YkyTdxxqWgFBp7yenOFw6y+7I5CUpdNy9g45LJigFdtNc8VZ5nKUxikkUigucRhzDifGkhrR ykR9QFc2g49W5iKjYUGquzTI9lV1YPGTAeKLSTrNIXa6BtIvoST/Z/thmBSevXpYdPlHBMulFxag jAYzB0pXZ501LV2BiYZ9/SbeAAAA//8DAFBLAQItABQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAA AAAAAAAAAAAAAAAAAABbQ29udGVudF9UeXBlc10ueG1sUEsBAi0AFAAGAAgAAAAhAK0wP/HBAAAA MgEAAAsAAAAAAAAAAAAAAAAANgEAAF9yZWxzLy5yZWxzUEsBAi0AFAAGAAgAAAAhAGAyLdffAQAA qgQAAB8AAAAAAAAAAAAAAAAAIAIAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWxQSwEC LQAUAAYACAAAACEAUD+iyxoHAABNIAAAGgAAAAAAAAAAAAAAAAA8BAAAY2xpcGJvYXJkL3RoZW1l L3RoZW1lMS54bWxQSwECLQAUAAYACAAAACEAnGZGQbsAAAAkAQAAKgAAAAAAAAAAAAAAAACOCwAA Y2xpcGJvYXJkL2RyYXdpbmdzL19yZWxzL2RyYXdpbmcxLnhtbC5yZWxzUEsFBgAAAAAFAAUAZwEA AJEMAAAAAA== " strokecolor="#156082 [3204]" strokeweight=".5pt" style="position:absolute; margin-left:240px; margin-top:18px; width:38pt; height:57pt; z-index:251661312" type="#_x0000_t32"><v:stroke endarrow="block" joinstyle="miter" startarrow="block"></v:stroke></v:shape><v:shape id="Straight_x0020_Arrow_x0020_Connector_x0020_2" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI +gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5 8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEANWgBzegBAAC0BAAA HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWykVNtunDAUfK/Uf7D83sCSZC8obFRt 0/ShaqJu+wFHxoBVc4xsl7B/32PMXrSKUiV5ARvPzJkztrm5HVrNemmdMljw2UXKmURhSoV1wX// +vppyZnzgCVog7LgO+n47frjhxvIawtdowQjBXQ5FLzxvsuTxIlGtuAuTCeR1ipjW/A0tXVSWngi 5VYnWZrOkxYU8vVR6gt4YH+teoOUNuKPLDeAPTiS1CI//TJ51OL9ypBjf2+7bfdog3Pxo3+0TJUF p+QQWoqIJ9PCBKNpcsaqjwJDZduAN1XFhoJn88VqkZLWjnZjlS6ur9KoJwfPBAGus3RcFwRYZJcr wsZ6zcN/FERz96IGmYxmaHBiUAy47YJD7DdheN73bL5azNPl8vJqH8DWW1B149lna80T2xhEKbyx LDtEMyntozkRdlOBYIVVWnXfKIjxkLwvoUN3kHfW+XtpWhYGBXeT3YPPWA76785Hg3tCSEFjeDYS yjssmd91tOPeKsBay9ieB6WfXyMPgU6vfZfO77SMsj9lReeIdjiWH2+R3GjLetAFByEk+lmoMKoQ OtAqpfWBmI4xvUic8IEqq4p25TXkA2OsbPBIbhUa+1x1P+wtVxEfu49dUyPT4UrO7uuImv4v4adw Ol//AwAA//8DAFBLAwQUAAYACAAAACEAUD+iyxoHAABNIAAAGgAAAGNsaXBib2FyZC90aGVtZS90 aGVtZTEueG1s7FpLbxs3EL4X6H8g9t5YkiXZMiIHli3HTfxCpKTIkZKoXcbc5YKk7OhWJKdeChRI i14K9NZDUTRAAzTopT/GQII2/REdch8iJSp+IECDwjZg7M5+MxzOzM7MDn37ztOYoVMiJOVJO6je qgSIJEM+oknYDh72dz9bD5BUOBlhxhPSDqZEBnc2P/3kNt4YMpoOOBajfkRigkBQIjdwO4iUSjdW VuQQyFje4ilJ4NmYixgruBXhykjgM1ggZiu1SqW5EmOaBJsgUWlBXQZ/EiU1YchET4shKMExrH40 HtMhMdjRSVUj5FRuM4FOMWsHIHPEz/rkqQoQw1LBg3ZQMT/ByubtFbyRMzG1hNfi2zU/OV/OMDqp mTVFOCgXrXRr6/VqKd8AmFrEddf1bynPAPBwCDvNdLFlVhvNynotx1qg7NIju7VWXXXxlvzVBZ2r rWanVnfkG1Amv76Ar+y2ujsNB29AGb6xgN+q1DqtVQdvQBm+uYCvd7fWal0Hb0ARo8nJIrq5tr7e zNElZMzZnhfeajYrazs5fIaCaCijSy8x5olaFmsxfsLFLgA0kGFFE6SmKRnjIcTkVqq4RDtUpgxP A5TihEsgV2rVKoRevVIrf43F8QbBFrfWCzSRCyStD5JDQVPVDu6B1MCCvHn9+vzZq/Nnv58/f37+ 7Fe0T8NIZaIcvj2chDbfu5+++eeHL9Hfv/347sW3fry08W9/+ertH3++Tzy8ajNTvPnu5dtXL998 //VfP7/wSN8SeGDD+zQmEh2SM/SAx7BBYwpXfzIQV+PoR5jaHFtJKHGC9Soe+V0VOejDKWbYg+sQ 146PBKQaH/Du5ImjcC8SE0U9Eu9HsQM84Jx1uPBa4b5eyzJzf5KE/sXFxMY9wPjUt/Y2Thwvdycp 5FjqE7kdEUfNY4YThUOSEIX0M35CiGd3jyl17HpAh4JLPlboMUUdTL0m6dOBE00zpj0ag1+mPgXB 345tDh6hDme+Xe+QUxcJ7wZmHuX7hDlmvIsnCsc+kX0cM9vg+1hFPiV7UzG0cV2pwNMhYRx1R0RK H8+RgP1aTr+PIbt53X7AprGLFIqe+GTuY85t5A4/2Y5wnPqwPZpENvZzeQIhitExVz74AXffEH0P fsDJUnc/osRx98XZ4CFkOVulWYDoJxPh8eVdwp347U3ZGBNfqtkSsZNitwT1RkdnEjqhvU8Iw2d4 RAh6+LlHgw5PHZvPlL4XQVbZI77AuofdWNX3CZEEmeZmMU/uU+mEbI+EfIk+B9O5xDPFSYzFMsmH 4HXb5t2BgJfRs88jNjyxgYcU+j2IF69RjiTIsIJ7qdTjCDsFTN9Lf7xOheO/y7xj8F4+cdS4xHsJ POTKPJDYbZ732qaPmbPALGD6mKJ9X7oFFsf9MxZdXA3bxMs3dl/amRugO3KanpgmF3RA/03n4wnE D9Pz+AU7CeuK3c6yhLI31+Msw813NttcjOjH39js4ElyTKCWLGatm77mpq8J/vd9zbL3+aabWdZz 3HQzAXQZN91MPmD5MN3MrIGB3kYPGbJhjxn9xEsnP2PKWE9NGdmXZvgj4ZtmtAtEzWcmnKScBKYR XOoyBws4uFBgw4MEV19QFfUinMKEqBpoIaHMRYcSpVzC4MiQvbI1nk3iAz7KBp5mwlTJKqvEakav NGD0lNFhWKUydHMtJ2r9zFQV9DXahmbYWiigea+ihLWYq8SqR4m1gniBEnp29mG0aHm0WNfiC1ct mAJUK70CH90IPtXbQaOuFYLxuBxCgz7SfspcXXjXOPNDenqZMZ0IgOFithOYnpeebmldl25P7y4L tUt42lHCOCULK1cJYxnT4MkIPoXz6NTUy6hxVV+3Zi511NOmMOtBfM/UWFt/nxbX9TXwzecGltiZ giXorB00VxsQMkOctoMxDI7hMk4hdqT+7sIshCOXoRLZC3+dzJIKqXawjDKDm6STuSemigjEaNwO 9PZLN7DE5BCjW7UGCeGjVa4FaeVjUw6c7jqZjMdkqGy3WxRt6ewWMnyWK7xPDfv1wZqTT8DdvWh0 hgZsIh5gCLHGWlUbcEQlnB9UM2uOKByIlYlsFn9zhSlP/vaJlImhjI5ZGuG8otjJPIObelKqY+5K G1h3+Z7BoJZJ8kI4CHWBtY3qVNOydGU6LK26FzNpy1lJc1Yznayiq6Y/izkrFGVgzpbXK/KWVoWJ IafZFT5L3fMpt1Xkurk+oawSYPDSftcr/ZZqs8Uc1bTGi2lY5+yc6taOYoMXqHaZImFl/WYhds5u ZY3wLgfEa1V+4JuPWiCNi77SWNp3uH2AUzQIq+0ADphhQPgUruCIOgBaTdNqmgZXcO4M5SI7LG4H +UVBgecZpcSsFpTVAlMvKPWC0igojYLSLCjNAJlTVTjJ1weqASoOTaGG5YeseW/h/gfA5r8AAAD/ /wMAUEsDBBQABgAIAAAAIQCcZkZBuwAAACQBAAAqAAAAY2xpcGJvYXJkL2RyYXdpbmdzL19yZWxz L2RyYXdpbmcxLnhtbC5yZWxzhI/NCsIwEITvgu8Q9m7SehCRJr2I0KvUBwjJNi02PyRR7Nsb6EVB 8LIws+w3s037sjN5YkyTdxxqWgFBp7yenOFw6y+7I5CUpdNy9g45LJigFdtNc8VZ5nKUxikkUigu cRhzDifGkhrRykR9QFc2g49W5iKjYUGquzTI9lV1YPGTAeKLSTrNIXa6BtIvoST/Z/thmBSevXpY dPlHBMulFxagjAYzB0pXZ501LV2BiYZ9/SbeAAAA//8DAFBLAQItABQABgAIAAAAIQC75UiUBQEA AB4CAAATAAAAAAAAAAAAAAAAAAAAAABbQ29udGVudF9UeXBlc10ueG1sUEsBAi0AFAAGAAgAAAAh AK0wP/HBAAAAMgEAAAsAAAAAAAAAAAAAAAAANgEAAF9yZWxzLy5yZWxzUEsBAi0AFAAGAAgAAAAh ADVoAc3oAQAAtAQAAB8AAAAAAAAAAAAAAAAAIAIAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5n MS54bWxQSwECLQAUAAYACAAAACEAUD+iyxoHAABNIAAAGgAAAAAAAAAAAAAAAABFBAAAY2xpcGJv YXJkL3RoZW1lL3RoZW1lMS54bWxQSwECLQAUAAYACAAAACEAnGZGQbsAAAAkAQAAKgAAAAAAAAAA AAAAAACXCwAAY2xpcGJvYXJkL2RyYXdpbmdzL19yZWxzL2RyYXdpbmcxLnhtbC5yZWxzUEsFBgAA AAAFAAUAZwEAAJoMAAAAAA== " strokecolor="#156082 [3204]" strokeweight=".5pt" style="position:absolute; margin-left:185px; margin-top:18px; width:41pt; height:57pt; flip:x; z-index:251659264" type="#_x0000_t32"><v:stroke endarrow="block" joinstyle="miter" startarrow="block"></v:stroke></v:shape>                                                     Ageing
 
                                  


<v:shape id="Straight_x0020_Arrow_x0020_Connector_x0020_3" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI +gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5 8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEAC/J2bdsBAAB5BAAA HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWykVNuO0zAUfEfiHyy/s0naKmWjTVeo LPuCYEXhA44cJ7FwjiPbZNO/5zi3VlGFBLw4vszMmfElD499o1knrVMGc57cxZxJFKZQWOX8x/dP 795z5jxgAdqgzPlZOv54ePvmAbLKQlsrwUgBXQY5r71vsyhyopYNuDvTSqS10tgGPA1tFRUWXkm5 0dEmjtOoAYX8cJH6CB7YL6v+QUob8VMWR8AOHElqkV3PTB61+H9lyLB7tu2pfbHBufjSvVimipzT ziE0tEU8mhYmGA2jFau6CPSlbQLelCXrB5VzaAcN2XsmxklxmRX11xtYUT/dQFPhsQB1roqKHk9t qIrdMXTXWdJdsk939/F+znTyFlRVe/bBWvPKjgZRCm8s2y5pJ6E57ZWum/RXUTfp/n4f07ZRtE26 TXa7VewkjrfbAFjCL3Ega63zz9I0LHRy7iaDi7NkuFjQfXZ+tDQTQmyNoa0lFE9YMH9u6di8VYCV lmMgD0rfXiMPgU6fOZfzZy1H2W+ypMtARzaWH56CPGrLOtA5ByEk+iRUGFQIHWil0nohxoPvPxIn fKDKsqRz+BvywhgqG7yQG4XG3qru+9lyOeLH9GNqCjLdpmj16AbU9JMIL/t6fPgNAAD//wMAUEsD BBQABgAIAAAAIQBQP6LLGgcAAE0gAAAaAAAAY2xpcGJvYXJkL3RoZW1lL3RoZW1lMS54bWzsWktv GzcQvhfofyD23liSJdkyIgeWLcdN/EKkpMiRkqhdxtzlgqTs6FYkp14KFEiLXgr01kNRNEADNOil P8ZAgjb9ER1yHyIlKn4gQIPCNmDszn4zHM7MzswOffvO05ihUyIk5Uk7qN6qBIgkQz6iSdgOHvZ3 P1sPkFQ4GWHGE9IOpkQGdzY//eQ23hgymg44FqN+RGKCQFAiN3A7iJRKN1ZW5BDIWN7iKUng2ZiL GCu4FeHKSOAzWCBmK7VKpbkSY5oEmyBRaUFdBn8SJTVhyERPiyEowTGsfjQe0yEx2NFJVSPkVG4z gU4xawcgc8TP+uSpChDDUsGDdlAxP8HK5u0VvJEzMbWE1+LbNT85X84wOqmZNUU4KBetdGvr9Wop 3wCYWsR11/VvKc8A8HAIO810sWVWG83Kei3HWqDs0iO7tVZddfGW/NUFnautZqdWd+QbUCa/voCv 7La6Ow0Hb0AZvrGA36rUOq1VB29AGb65gK93t9ZqXQdvQBGjyckiurm2vt7M0SVkzNmeF95qNitr Ozl8hoJoKKNLLzHmiVoWazF+wsUuADSQYUUTpKYpGeMhxORWqrhEO1SmDE8DlOKESyBXatUqhF69 Uit/jcXxBsEWt9YLNJELJK0PkkNBU9UO7oHUwIK8ef36/Nmr82e/nz9/fv7sV7RPw0hlohy+PZyE Nt+7n77554cv0d+//fjuxbd+vLTxb3/56u0ff75PPLxqM1O8+e7l21cv33z/9V8/v/BI3xJ4YMP7 NCYSHZIz9IDHsEFjCld/MhBX4+hHmNocW0kocYL1Kh75XRU56MMpZtiD6xDXjo8EpBof8O7kiaNw LxITRT0S70exAzzgnHW48Frhvl7LMnN/koT+xcXExj3A+NS39jZOHC93JynkWOoTuR0RR81jhhOF Q5IQhfQzfkKIZ3ePKXXsekCHgks+VugxRR1MvSbp04ETTTOmPRqDX6Y+BcHfjm0OHqEOZ75d75BT FwnvBmYe5fuEOWa8iycKxz6RfRwz2+D7WEU+JXtTMbRxXanA0yFhHHVHREofz5GA/VpOv48hu3nd fsCmsYsUip74ZO5jzm3kDj/ZjnCc+rA9mkQ29nN5AiGK0TFXPvgBd98QfQ9+wMlSdz+ixHH3xdng IWQ5W6VZgOgnE+Hx5V3CnfjtTdkYE1+q2RKxk2K3BPVGR2cSOqG9TwjDZ3hECHr4uUeDDk8dm8+U vhdBVtkjvsC6h91Y1fcJkQSZ5mYxT+5T6YRsj4R8iT4H07nEM8VJjMUyyYfgddvm3YGAl9GzzyM2 PLGBhxT6PYgXr1GOJMiwgnup1OMIOwVM30t/vE6F47/LvGPwXj5x1LjEewk85Mo8kNhtnvfapo+Z s8AsYPqYon1fugUWx/0zFl1cDdvEyzd2X9qZG6A7cpqemCYXdED/TefjCcQP0/P4BTsJ64rdzrKE sjfX4yzDzXc221yM6Mff2OzgSXJMoJYsZq2bvuamrwn+933Nsvf5pptZ1nPcdDMBdBk33Uw+YPkw 3cysgYHeRg8ZsmGPGf3ESyc/Y8pYT00Z2Zdm+CPhm2a0C0TNZyacpJwEphFc6jIHCzi4UGDDgwRX X1AV9SKcwoSoGmghocxFhxKlXMLgyJC9sjWeTeIDPsoGnmbCVMkqq8RqRq80YPSU0WFYpTJ0cy0n av3MVBX0NdqGZthaKKB5r6KEtZirxKpHibWCeIESenb2YbRoebRY1+ILVy2YAlQrvQIf3Qg+1dtB o64VgvG4HEKDPtJ+ylxdeNc480N6epkxnQiA4WK2E5iel55uaV2Xbk/vLgu1S3jaUcI4JQsrVwlj GdPgyQg+hfPo1NTLqHFVX7dmLnXU06Yw60F8z9RYW3+fFtf1NfDN5waW2JmCJeisHTRXGxAyQ5y2 gzEMjuEyTiF2pP7uwiyEI5ehEtkLf53MkgqpdrCMMoObpJO5J6aKCMRo3A709ks3sMTkEKNbtQYJ 4aNVrgVp5WNTDpzuOpmMx2SobLdbFG3p7BYyfJYrvE8N+/XBmpNPwN29aHSGBmwiHmAIscZaVRtw RCWcH1Qza44oHIiViWwWf3OFKU/+9omUiaGMjlka4byi2Mk8g5t6Uqpj7kobWHf5nsGglknyQjgI dYG1jepU07J0ZTosrboXM2nLWUlzVjOdrKKrpj+LOSsUZWDOltcr8pZWhYkhp9kVPkvd8ym3VeS6 uT6hrBJg8NJ+1yv9lmqzxRzVtMaLaVjn7Jzq1o5igxeodpkiYWX9ZiF2zm5ljfAuB8RrVX7gm49a II2LvtJY2ne4fYBTNAir7QAOmGFA+BSu4Ig6AFpN02qaBldw7gzlIjssbgf5RUGB5xmlxKwWlNUC Uy8o9YLSKCiNgtIsKM0AmVNVOMnXB6oBKg5NoYblh6x5b+H+B8DmvwAAAP//AwBQSwMEFAAGAAgA AAAhAJxmRkG7AAAAJAEAACoAAABjbGlwYm9hcmQvZHJhd2luZ3MvX3JlbHMvZHJhd2luZzEueG1s LnJlbHOEj80KwjAQhO+C7xD2btJ6EJEmvYjQq9QHCMk2LTY/JFHs2xvoRUHwsjCz7DezTfuyM3li TJN3HGpaAUGnvJ6c4XDrL7sjkJSl03L2DjksmKAV201zxVnmcpTGKSRSKC5xGHMOJ8aSGtHKRH1A VzaDj1bmIqNhQaq7NMj2VXVg8ZMB4otJOs0hdroG0i+hJP9n+2GYFJ69elh0+UcEy6UXFqCMBjMH SldnnTUtXYGJhn39Jt4AAAD//wMAUEsBAi0AFAAGAAgAAAAhALvlSJQFAQAAHgIAABMAAAAAAAAA AAAAAAAAAAAAAFtDb250ZW50X1R5cGVzXS54bWxQSwECLQAUAAYACAAAACEArTA/8cEAAAAyAQAA CwAAAAAAAAAAAAAAAAA2AQAAX3JlbHMvLnJlbHNQSwECLQAUAAYACAAAACEAC/J2bdsBAAB5BAAA HwAAAAAAAAAAAAAAAAAgAgAAY2xpcGJvYXJkL2RyYXdpbmdzL2RyYXdpbmcxLnhtbFBLAQItABQA BgAIAAAAIQBQP6LLGgcAAE0gAAAaAAAAAAAAAAAAAAAAADgEAABjbGlwYm9hcmQvdGhlbWUvdGhl bWUxLnhtbFBLAQItABQABgAIAAAAIQCcZkZBuwAAACQBAAAqAAAAAAAAAAAAAAAAAIoLAABjbGlw Ym9hcmQvZHJhd2luZ3MvX3JlbHMvZHJhd2luZzEueG1sLnJlbHNQSwUGAAAAAAUABQBnAQAAjQwA AAAA " strokecolor="#156082 [3204]" strokeweight=".5pt" style="position:absolute; margin-left:185px; margin-top:2px; width:79pt; height:0; z-index:251660288" type="#_x0000_t32"><v:stroke endarrow="block" joinstyle="miter" startarrow="block"></v:stroke></v:shape>                                      NER                            Iatrogenic genotoxins        


Aging is a complex biological process characterized by the gradual decline in physiological functions and increased vulnerability to various diseases, including cancer. One of the key factors contributing to aging is the accumulation of DNA damage over time. DNA repair mechanisms, such as Nucleotide Excision Repair (NER), play a crucial role in maintaining genomic stability by repairing a wide range of DNA lesions. Since my research topic is related to DNA damage response pathways, specifically NER. I would like to show a connection between NER and aging. Additionally,  I would like to show connection between aging and Iatrogenic genotoxins.

Part I

Firsly, lets start with NER.Understanding the relationship between aging and NER involves exploring how changes in NER efficiency contribute to the aging process and age-related diseases.
NER is a versatile DNA repair pathway responsible for detecting and removing bulky DNA lesions caused by ultraviolet (UV) radiation, chemical mutagens, and oxidative stress. These lesions can distort the DNA helix, interfering with transcription and replication. The NER process involves several steps:
Damage Recognition: NER can be initiated through two sub-pathways: Global Genomic NER (GG-NER) and Transcription-Coupled NER (TC-NER). GG-NER scans the entire genome for lesions, while TC-NER specifically targets lesions that block transcription.
Damage Excision: After lesion recognition, the DNA surrounding the damage is unwound, and a short single-stranded DNA segment containing the lesion is excised.
DNA Synthesis and Ligation:The resulting gap is filled by DNA polymerase using the undamaged strand as a template, and the newly synthesized DNA is ligated to restore the DNA backbone.
Aging and Decline in NER Efficiency
Research indicates that the efficiency of NER declines with age, which contributes to the accumulation of DNA damage. Several factors are implicated in this decline are:
Firstly, decreased expression of NER genes: The expression levels of critical NER genes, such as those encoding for the XPA, XPC, and ERCC1 proteins, have been shown to decrease with age. This reduction in gene expression leads to a lower availability of essential repair proteins, compromising the overall efficiency of the NER pathway.
Secondly, post-translational modifications:Age-related changes in post-translational modifications of NER proteins can affect their stability, localization, and interaction with other repair factors. For instance, oxidative stress can lead to the modification of repair proteins, impairing their function.
Thirdly, epigenetic changes: Epigenetic modifications, such as DNA methylation and histone acetylation, change with age and can influence the accessibility of NER machinery to damaged sites. These changes can result in reduced recruitment and assembly of repair complexes at DNA lesions.
Lastly, accumulation of senescent cells: Senescent cells, which are characterized by a permanent cell cycle arrest, accumulate with age and exhibit a senescence-associated secretory phenotype (SASP). These cells can secrete factors that promote inflammation and tissue dysfunction, indirectly affecting NER efficiency by altering the tissue microenvironment.
Implications for Age-Related Diseases
The decline in NER efficiency with age has significant implications for age-related diseases, particularly cancer and neurodegenerative disorders:
Cancer: Reduced NER activity leads to an accumulation of DNA damage, increasing the risk of mutations that can drive carcinogenesis. Age-related decline in NER is associated with a higher incidence of skin cancers, such as basal cell carcinoma and melanoma, which are linked to UV-induced DNA damage.
Neurodegenerative Diseases:Neurons are particularly susceptible to DNA damage due to their high metabolic activity and limited capacity for regeneration. Impaired NER in aging neurons contributes to the accumulation of DNA lesions, which can disrupt transcription and neuronal function, potentially leading to neurodegenerative diseases such as Alzheimer's and Parkinson's.

Understanding the relationship between aging and NER opens avenues for potential interventions aimed at enhancing DNA repair capacity and mitigating age-related decline. I can suggest the folowing potential interventions according to my research on this topic.
Gene Therapy:Introducing or upregulating key NER genes through gene therapy could help restore NER efficiency in aged cells, reducing DNA damage accumulation and its associated effects.
Pharmacological Agents: Developing drugs that enhance the activity of NER proteins or protect them from age-related modifications could improve DNA repair capacity. Antioxidants, for example, might reduce oxidative damage to NER proteins and DNA.
Lifestyle Interventions: Lifestyle factors, such as a healthy diet rich in antioxidants, and avoidance of excessive UV exposure, can help minimize DNA damage and support DNA repair mechanisms.

The relationship between aging and Nucleotide Excision Repair is a critical aspect of understanding the biological mechanisms underlying aging and age-related diseases. The decline in NER efficiency with age contributes to the accumulation of DNA damage, increasing the risk of cancer and neurodegenerative disorders. By exploring the factors that influence NER activity and developing strategies to enhance DNA repair capacity, we can potentially mitigate some of the adverse effects of aging and improve healthspan and longevity.
Part II
In my opinion, there are sufficient and diverse evidence to support a cogent argument that DNA damage plays a causal role in aging. This includes environmental/iatrogenic sources of genotoxic stress as well as spontaneous/endogenous genotoxic stress. DNA damage contributes to aging via cell autonomous events such as causing apoptosis, which depletes functional cells such as neurons, and via cell non-autonomous mechanisms such as triggering senescence which all effect neighboring cells. DNA damage, once detected  should be repaired. If no repair occurs, can interfere with biological function of the cells.It can also result in mitochondrial dysfunction, impaired autophagy, metabolic changes, and the triggering of cellular. These live but physiologically altered cells are predicted to be a more potent driver of aging and disease.
The number of cancer survivors is increasing dramatically as a consequence of improved therapeutics. Unfortunetaly, these patients treated with  genetoxic agents are aged rapidly. Radiation and genotoxic chemotherapy are used to kill rapidly dividing cells, like tumor cells. However, It will not directly recognize cancer cells. All cells in the body can experience genotoxic stress induced by chemotherapy/radiotherapy which later triggering aging. In my opinion, whether DNA damage is increased by exposure to genotoxins or by genetic depletion of repair mechanisms, the consequence might be the same: accelerated aging.
This supports the notion that DNA damage, regardless of whether the source is endogenous or exogenous, can be both the why and how aging occurs.
In my research, I usedcisplatin, carboplatin, and oxaliplatin which are FDA-approved platinum-based anti-tumor drugs (Genotoxins) used in chemotherapy regimens.Their therapeutic efficacy is principally attributed to the formation of DNA intrastrand and interstrand cross-links, which disrupt vital cellular processes such as DNA replication, ultimately triggering apoptosis and cell death. Despite their clinical significance, the emergence of drug resistance and adverse side effects pose substantial challenges to the efficacy and tolerability of platinum-based chemotherapy.Resistance of platinum drugs is the major drawback to the clinical success of the drug and overcoming it remains one of the main goals for the anticancer therapy.To use platinum drugs in a more targeted manner new approaches are needed to predict therapy response.Our laboratory aimed to address these challenges through the development of comprehensive ultraperformance liquid chromatography-selective ion monitoring (UPLC-SIM) assays. To quantify various types of DNA intrastrand cross-links induced by platinum drugs, including 1,2-GG, 1,2-AG, 1,3-GCG, and 1,3-GTG cross-links.One powerful approach to elucidate reactivity with DNA and to measure the persistence of platinum-DNA adducts in cells would be to determine the levels of different types of cisplatin-DNA crosslinks in genomic DNA.
I aimed to develop a complementary assay to investigate the repair kinetics of platinum intrastrand crosslinks by nucleotide excision repair (NER). For this purpose, I adapted alkaline COMET chip assays. To precisely measure NER incision rates in response to platinum drug-induced DNA-DNA breaks within G1 phase cells. Through this assay, I aimed to elucidate the important interplay between NER-mediated repair processes and the cytotoxic effects of platinum drugs.
By additionally studying the repair mechanisms associated with platinum drug therapy, I aimed to contribute to the development of more efficacious and targeted treatment strategies for overcoming platinum resistance mechanisms in cancer therapy.
Indeed, this approach may serve as a valuable tool to complement the study of DNA adduct formation and repair in cells.Additionaly, these assays can be used as a diagnostic tool to study how NER contribute to sensitivity of the cancer cells to platinum drugs. Many types of tumor, such as testicular, breast, ovarian and bladder cancer are treated with platinum drugs.
If a patient has resistance to platinum drugs, we can identify this with our therapeutic tool. There is no need to subject the patient to more genotoxic stress if the therapy will not be effective. I believe that fighting cancer means fighting aging.
Concluding remarks from Asema
For me, learning is about training my mind. Through this course, I feel like I have gained a lot of useful knowledge. However, I am still striving to explore more. This course has shown me that there are many talented peers whom I need to look up to for further improvement in generating ideas and conducting research.
Professor Jong told us in class that grades are a tool. In my opinion, I have earned the highest grade, which will increase my GPA. I can use this tool for my future PhD application. My future goal is to dive into the world of science, which I love the most.